awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33391725-7AC6401E-C6ED-4266-AFE2-14C49B8F6DC0
Q33391725-7AC6401E-C6ED-4266-AFE2-14C49B8F6DC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33391725-7AC6401E-C6ED-4266-AFE2-14C49B8F6DC0
Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG).
P2860
Q33391725-7AC6401E-C6ED-4266-AFE2-14C49B8F6DC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33391725-7AC6401E-C6ED-4266-AFE2-14C49B8F6DC0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
157a27f8e5c0a16c96b99f14c8d8130ed9c803c2
P2860
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies.